| Structure |
Chemical Name |
CAS |
MF |
 |
Surzebiclimab |
2342597-90-2 |
|
 |
SD-101 |
1263078-66-5 |
|
 |
フェラジリマブ(遺伝子組換え) |
2252518-85-5 |
|
 |
Oportuzumab Monatox |
945228-48-8 |
|
 |
Lirilumab |
1000676-41-4 |
|
![Glycinamide, N2-[2-[2-[2-[[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]amino]ethoxy]ethoxy]acetyl]-N-[(2S)-2-[4-(β-D-glucopyranuronosyloxy)-3-nitrophenyl]-2-[[[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-1-yl]amino]carbonyl]oxy]ethyl]-L-glutaminyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-meth](/CAS/20250703/GIF/2983134-61-6.gif) |
Glycinamide, N2-[2-[2-[2-[[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]amino]ethoxy]ethoxy]acetyl]-N-[(2S)-2-[4-(β-D-glucopyranuronosyloxy)-3-nitrophenyl]-2-[[[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-1-yl]amino]carbonyl]oxy]ethyl]-L-glutaminyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-meth |
2983134-61-6 |
C87H112FN19O33 |
 |
L-Asparagine, N-(1-β-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-, hydrochloride (1:1) |
2098942-57-3 |
C13H19ClN4O8 |
 |
Milademetan |
1398568-47-2 |
C30H34Cl2FN5O4 |
 |
Mal-Bal-Ph(β-D-Glucose)-7-MAD-MDCPT |
2396667-62-0 |
C46H44N6O19 |
 |
Zanidatamab |
2169946-15-8 |
|
 |
アミバンタマブ(遺伝子組換え) |
2171511-58-1 |
|
 |
Vopratelimab |
2039148-04-2 |
|
 |
Vecabrutinib succinate |
1947403-49-7 |
C26H30ClF4N7O6 |
 |
キシノスタット塩酸塩 |
1083078-98-1 |
C21H27ClN6O2 |
 |
オンブラブリン塩酸塩 |
253426-24-3 |
C21H26N2O6.ClH |
 |
CLR-131 |
873438-88-1 |
C29H53INO4P |
 |
アンナマイシン |
92689-49-1 |
C26H25IO11 |
 |
HM-30181 mesylate monohydrate |
2097125-58-9 |
C39H40N6O10S |
 |
AZD0364 |
2097416-76-5 |
C24H24F2N8O2 |
 |
Imgatuzumab |
959963-46-3 |
|
![Pyrazolo[1,5-a]pyrimidine, 5-[(2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]-3-[4-(trifluoromethyl)-1H-pyrazol-1-yl]-](/CAS/20210305/GIF/2353522-15-1.gif) |
Pyrazolo[1,5-a]pyrimidine, 5-[(2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]-3-[4-(trifluoromethyl)-1H-pyrazol-1-yl]- |
2353522-15-1 |
C20H15F5N6 |
 |
Research Grade Inbakicept (DHE28302) |
2135939-52-3 |
|
 |
Mipasetamab |
2361055-48-1 |
|
 |
MilatuzuMab |
899796-83-9 |
|
 |
Fexapotide triflutate |
1609252-56-3 |
C92H164F3N27O27S |
 |
Ispinesib mesylate |
514820-03-2 |
C31H37ClN4O5S |
 |
Linavonkibart |
2640981-30-0 |
|
 |
KX2-391 (Mesylate) |
1080645-95-9 |
C27H33N3O6S |
 |
ベキスロステリド |
148905-78-6 |
C14H16ClNO |
 |
Casdozokitug |
2643331-37-5 |
|
 |
エプラツズマブ |
205923-57-5 |
|
 |
リフィラフェニブ |
1446090-79-4 |
C25H17F3N4O3 |
 |
2-Buten-1-amine, 3-fluoro-4-(8-quinolinylsulfonyl)-, (2Z)- |
2409963-83-1 |
C13H13FN2O2S |
![L-Alaninamide, N-[10,10-dioxido-1,12-dioxo-14-[(1α,8α,9β)-bicyclo[6.1.0]non-4-yn-9-yl]-3,6,13-trioxa-10-thia-9,11-diazatetradec-1-yl]-L-valyl-N-[4-[[[[(11S,11aS)-8-[[5-[[(11aS)-5,11a-dihydro-7-methoxy-2-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]pentyl]oxy]-11,11a-dihydro-11-hydroxy-7-methoxy-2-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl]carbonyl]oxy]methyl]phenyl]-](/CAS/20240320/GIF/2126805-05-6.gif) |
L-Alaninamide, N-[10,10-dioxido-1,12-dioxo-14-[(1α,8α,9β)-bicyclo[6.1.0]non-4-yn-9-yl]-3,6,13-trioxa-10-thia-9,11-diazatetradec-1-yl]-L-valyl-N-[4-[[[[(11S,11aS)-8-[[5-[[(11aS)-5,11a-dihydro-7-methoxy-2-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]pentyl]oxy]-11,11a-dihydro-11-hydroxy-7-methoxy-2-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl]carbonyl]oxy]methyl]phenyl]- |
2126805-05-6 |
C66H83N9O18S |
![7H-8,12-Metheno-4H-pyrazolo[3,4-h]-1,2,3-triazolo[4,5-k][2,5]benzoxaazacyclotetradecin-11-amine, 7-ethyl-16-fluoro-2,14-dihydro-2,14-dimethyl-, (14R)-](/CAS/20211123/GIF/2739829-00-4.gif) |
7H-8,12-Metheno-4H-pyrazolo[3,4-h]-1,2,3-triazolo[4,5-k][2,5]benzoxaazacyclotetradecin-11-amine, 7-ethyl-16-fluoro-2,14-dihydro-2,14-dimethyl-, (14R)- |
2739829-00-4 |
C22H22FN7O |
 |
サマリウム (153Sm)レキシドロナムナトリウム |
160369-78-8 |
C6H12N2Na5O12P4Sm |
 |
イタシチニブアジピン酸塩 |
1334302-63-4 |
C32H33F4N9O5 |
![4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)-](/CAS/20200515/GIF/1801344-14-8.gif) |
4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- |
1801344-14-8 |
C24H25N7O5 |
 |
ラバクホサジン |
859209-74-8 |
C21H35N8O6P |
 |
Falbikitug |
2740565-02-8 |
|
 |
チノスタムスチン |
1236199-60-2 |
C19H28Cl2N4O2 |
![1-Pyrrolidinecarboxamide, 3,3-dimethyl-N-[6-methyl-5-[[2-(1-methyl-1H-pyrazol-4-yl)-4-pyridinyl]oxy]-2-pyridinyl]-2-oxo-, hydrochloride, hydrate (1:1:1)](/CAS/20240320/GIF/2759304-23-7.gif) |
1-Pyrrolidinecarboxamide, 3,3-dimethyl-N-[6-methyl-5-[[2-(1-methyl-1H-pyrazol-4-yl)-4-pyridinyl]oxy]-2-pyridinyl]-2-oxo-, hydrochloride, hydrate (1:1:1) |
2759304-23-7 |
C22H24N6O3.ClH.H2O |
 |
トレバナニブ(遺伝子組換え) |
894356-79-7 |
|
 |
サラカチニブフマル酸塩 |
893428-72-3 |
C31H36ClN5O9 |
 |
4F-ベンゾイル-TN14003 |
664334-36-5 |
C97H144FN33O19S2 |
 |
レビマスタト |
259188-38-0 |
C23H41N5O5S |
 |
Research Grade Davutamig |
2648058-48-2 |
|
 |
ピマセルチブ塩酸塩 |
1236361-78-6 |
C15H16ClFIN3O3 |
 |
アシビシン |
42228-92-2 |
C5H7ClN2O3 |
 |
Fexapotide |
492447-54-8 |
C90H163N27O25S |
 |
(S)-CFT7455 |
2504235-67-8 |
C28H27N3O4 |
 |
Amatuximab |
931402-35-6 |
|
 |
1H-Isoindole-4-carboxamide, 2-(1-cyclohexyl-4-piperidinyl)-6-fluoro-2,3-dihydro-3-oxo- |
1606995-47-4 |
C20H26FN3O2 |
 |
メノガリル |
71628-96-1 |
C28H31NO10 |
 |
Cobomarsensodium |
1848257-85-1 |
|
 |
エディコチニブ |
1142363-52-7 |
C27H35N5O2 |
 |
Pegdinetanib |
906450-24-6 |
C27H46N6O13S |
 |
タノマスタット |
179545-77-8 |
C23H19ClO3S |
 |
Berubicin hydrochloride |
293736-67-1 |
C34H35NO11. HCl |
![Glycinamide, N-[6-[2-(methylsulfonyl)-5-pyrimidinyl]-1-oxo-5-hexyn-1-yl]-L-valyl-N6,N6-dipropyl-L-lysyl-N-[[3-[(7S)-7-ethyl-7,8,11,13-tetrahydro-7-hydroxy-8,11-dioxo-10H-1,3-dioxolo[4,5-g]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-14-yl]propoxy]methyl]-](/CAS/20240320/GIF/2821770-49-2.gif) |
Glycinamide, N-[6-[2-(methylsulfonyl)-5-pyrimidinyl]-1-oxo-5-hexyn-1-yl]-L-valyl-N6,N6-dipropyl-L-lysyl-N-[[3-[(7S)-7-ethyl-7,8,11,13-tetrahydro-7-hydroxy-8,11-dioxo-10H-1,3-dioxolo[4,5-g]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-14-yl]propoxy]methyl]- |
2821770-49-2 |
C55H71N9O13S |
 |
エルサマイシンA |
97068-30-9 |
C33H35NO13 |
 |
Cofetuzumab |
1869928-62-0 |
|
 |
Research Grade Sozinibercept |
2568358-31-4 |
|
 |
Oncophage |
492448-75-6 |
|
 |
Vonlerolizumab |
1638935-72-4 |
|
 |
サリデギブ |
1037210-93-7 |
C29H48N2O3S |
 |
Mirvetuximab Soravtansine |
1453084-37-1 |
|
 |
Ensituximab |
1092658-06-4 |
|
 |
エンザスタウリン塩酸塩 |
359017-79-1 |
C32H29N5O2.ClH |
 |
エルブロゾール |
124784-31-2 |
C24H27N3O5S |
 |
Ozuriftamab |
2460399-44-2 |
|
 |
ネバニミブ |
133825-80-6 |
C27H39N3O |
 |
Farletuzumab ecteribulin |
2407465-18-1 |
|
 |
Pelidotin |
1438849-92-3 |
C68H100N12O14S |
 |
エソルビシン塩酸塩 |
63950-06-1 |
C27H29NO10.ClH |
 |
ゾルバマイシン |
11056-20-5 |
C55H85N19O21S2 |
![[2,5′-Bi-1H-imidazole]-5-carboxamide, 4′-(4-fluorophenyl)-1′-(1-methylethyl)-N-[4-(4-methyl-1-piperazinyl)phenyl]-, acetate (1:1)](/CAS/20250703/GIF/2945838-77-5.gif) |
[2,5′-Bi-1H-imidazole]-5-carboxamide, 4′-(4-fluorophenyl)-1′-(1-methylethyl)-N-[4-(4-methyl-1-piperazinyl)phenyl]-, acetate (1:1) |
2945838-77-5 |
C27H30FN7O.C2H4O2 |
 |
Pacanalotamab |
2251756-52-0 |
|
 |
Depatuxizumab |
1471999-69-5 |
|
![Phenanthro[1,10,9,8-opqra]perylene-7,14-dione, 1,3,4,6,8,13-hexahydroxy-10,11-dimethyl-](/CAS/20210305/GIF/1372719-41-9.gif) |
Phenanthro[1,10,9,8-opqra]perylene-7,14-dione, 1,3,4,6,8,13-hexahydroxy-10,11-dimethyl- |
1372719-41-9 |
C30H16O8 |
 |
パリホスファミド |
31645-39-3 |
C4H11Cl2N2O2P |
![L-Alanine, N-[(S)-[[(2S,4S)-4-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,3-dioxolan-2-yl]methoxy](4-bromophenoxy)phosphinyl]-, (1S)-1-methylbutyl ester](/CAS/20210305/GIF/2129993-56-0.gif) |
L-Alanine, N-[(S)-[[(2S,4S)-4-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,3-dioxolan-2-yl]methoxy](4-bromophenoxy)phosphinyl]-, (1S)-1-methylbutyl ester |
2129993-56-0 |
C22H30BrN4O8P |
 |
トシル酸インプロスルファン |
32784-82-0 |
|
![2-Piperazineacetonitrile, 4-[(7S)-7-[3-amino-2-fluoro-5-methyl-6-(trifluoromethyl)phenyl]-2-[[(2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy]-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-4-yl]-1-(2-fluoro-1-oxo-2-propen-1-yl)-, (2S)-](/CAS/20210305/GIF/2914919-85-8.gif) |
2-Piperazineacetonitrile, 4-[(7S)-7-[3-amino-2-fluoro-5-methyl-6-(trifluoromethyl)phenyl]-2-[[(2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy]-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-4-yl]-1-(2-fluoro-1-oxo-2-propen-1-yl)-, (2S)- |
2914919-85-8 |
C32H35F6N7O3 |
![6H-Imidazo[4,5-f]quinoline-6-carboxylic acid, 3-[(1R,3R)-3-carboxycyclohexyl]-2-[(R)-(5-fluoro-2-methoxyphenyl)hydroxymethyl]-3,7,8,9-tetrahydro-7-methyl-, 6-methyl ester, (7S)-](/CAS/20210305/GIF/2304372-79-8.gif) |
6H-Imidazo[4,5-f]quinoline-6-carboxylic acid, 3-[(1R,3R)-3-carboxycyclohexyl]-2-[(R)-(5-fluoro-2-methoxyphenyl)hydroxymethyl]-3,7,8,9-tetrahydro-7-methyl-, 6-methyl ester, (7S)- |
2304372-79-8 |
C28H32FN3O6 |
 |
Loncastuximab Tesirine |
1879918-31-6 |
|
![(2S)-2-[[(2S)-6,8-Difluoro-1,2,3,4-tetrahydro-2-naphthalenyl]amino]-N-[1-[2-[(2,2-dimethylpropyl)amino]-1,1-dimethylethyl]-1H-imidazol-4-yl]pentanamide dihydrobromide](/CAS/20200119/GIF/1962925-29-6.gif) |
(2S)-2-[[(2S)-6,8-Difluoro-1,2,3,4-tetrahydro-2-naphthalenyl]amino]-N-[1-[2-[(2,2-dimethylpropyl)amino]-1,1-dimethylethyl]-1H-imidazol-4-yl]pentanamide dihydrobromide |
1962925-29-6 |
C27H42BrF2N5O |
 |
ベロテカン塩酸塩 |
213819-48-8 |
C25H28ClN3O4 |
 |
Omburtamab |
1895083-75-6 |
|
![L-Alanine, N-[(S)-[[(2S,4S)-4-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,3-dioxolan-2-yl]methoxy](4-bromophenoxy)phosphinyl]-, (1S)-1-methylbutyl ester, hydrochloride (1:1)](/CAS/20210305/GIF/2416950-25-7.gif) |
L-Alanine, N-[(S)-[[(2S,4S)-4-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,3-dioxolan-2-yl]methoxy](4-bromophenoxy)phosphinyl]-, (1S)-1-methylbutyl ester, hydrochloride (1:1) |
2416950-25-7 |
C22H30BrN4O8P.ClH |
 |
ビンタフォリド |
742092-03-1 |
C86H109N21O26S2 |
 |
Trastuzumab Duocarmazine |
1642152-40-6 |
|
 |
Bomedemstat |
1990504-72-7 |
C35H42FN7O5S |
 |
Pegamotecan |
581079-18-7 |
C50H44N6O13(C2H4O)n |
 |
ティボザニブ塩酸塩水和物 |
682745-41-1 |
C22H22Cl2N4O6 |
 |
アムバチニブ塩酸塩 |
1055986-67-8 |
C23H22ClN5O3S |
 |
レバスチニブトシル酸塩 |
1033893-29-6 |
CH6ClNO |
![L-Lysine, 4N6,4′N6-[1,1′-[3,6,10,13,16,19-hexaazabicyclo[6.6.6]eicosane-1,8-diylbis[imino(1,5-dioxo-5,1-pentanediyl)]]bis(D-phenylalanyl-D-phenylalanyl-8-aminooctanoyl)]bis[N2-[[[(1S)-1,3-dicarboxypropyl]amino]carbonyl]-](/CAS/20240320/GIF/2254661-83-9.gif) |
L-Lysine, 4N6,4′N6-[1,1′-[3,6,10,13,16,19-hexaazabicyclo[6.6.6]eicosane-1,8-diylbis[imino(1,5-dioxo-5,1-pentanediyl)]]bis(D-phenylalanyl-D-phenylalanyl-8-aminooctanoyl)]bis[N2-[[[(1S)-1,3-dicarboxypropyl]amino]carbonyl]- |
2254661-83-9 |
C100H150N20O24 |
![1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N′-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]-, (2E)-2-butenedioate (2:1)](/CAS/20210305/GIF/2444285-59-8.gif) |
1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N′-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]-, (2E)-2-butenedioate (2:1) |
2444285-59-8 |
C29H25FN4O5.1/2C4H4O4 |
 |
L-Tyrosine, N-acetylglycyl-L-valyl-L-arginyl-L-alanyl-L-lysyl-L-alanylglycyl-L-valyl-L-arginyl-L-asparaginyl-L-norleucyl-L-phenylalanyl-L-lysyl-L-seryl-L-α-glutamyl-L-seryl- |
2098662-44-1 |
C85H138N26O25 |